David M. Epstein - Officer Title: President and Chief Executive Officer, Director at Black Diamond Therapeutics, Inc.

Issuer-level insider activity

Role
Officer Title: President and Chief Executive Officer, Director
Issuer ticker
BDTX on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by David M. Epstein since 17 Aug 2025

Reported holdings for David M. Epstein in Black Diamond Therapeutics, Inc.

Form 4 holding Officer Title: President and Chief Executive Officer, Director

Black Diamond Therapeutics, Inc.

Security class
Common Stock
Shares / value
671,423
Estimated value
$1,832,985
Report date
27 Jun 2023
Price
$2.73
Ownership
Direct
Form 4 holding Officer Title: President and Chief Executive Officer, Director

Black Diamond Therapeutics, Inc.

Security class
Common Stock
Shares / value
16,579
Estimated value
$45,261
Report date
27 Jun 2023
Price
$2.73
Ownership
Indirect

Transaction history for David M. Epstein in Black Diamond Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .